Klopam Lite Tablet is a combination medication containing Clonazepam 0.25 mg and Escitalopram Oxalate 10 mg, indicated for the management of anxiety disorders, panic attacks, and depressive symptoms. Clonazepam, a benzodiazepine, exerts anxiolytic, anticonvulsant, and muscle-relaxant effects by enhancing the activity of gamma-aminobutyric acid (GABA) in the central nervous system, thereby producing a calming effect. Escitalopram Oxalate, a selective serotonin reuptake inhibitor (SSRI), increases serotonin levels in the brain, contributing to improved mood and reduced anxiety. The combination of these agents provides a synergistic effect, targeting both acute anxiety symptoms and underlying depressive states. Klopam Lite is typically prescribed when monotherapy is insufficient or when rapid symptom control is desired alongside long-term mood stabilization. Dosage should be individualized based on patient response and tolerability, with careful monitoring for potential side effects such as drowsiness, dizziness, gastrointestinal disturbances, and risk of dependence associated with clonazepam. Caution is advised in patients with a history of substance abuse, respiratory disorders, or hepatic impairment. Abrupt discontinuation should be avoided to prevent withdrawal symptoms. Klopam Lite should be used under strict medical supervision to ensure safety and efficacy.